Giving Franky three hundred pig brains, he never expected that Yang Rui would go to develop new drugs.

When Frankie gave her another 600 pig brains, she never expected that Yang Rui said that she would actually produce active substances when she said that she would develop new drugs.

Of course, active substances can also be regarded as drugs. The process of developing new drugs is extremely cumbersome. If the work in the laboratory is distributed based on the workload, it may be less than half of the total work. Yang Rui’s current part is far away from one-third of the laboratory work.

Despite this, Franky hasn't heard anything like that from other companies.

Arnold, who was seduced by him, had never heard of anything similar.

In fact, than Frank's accustomed to shock, Comrade Arnold faced the shock as an entry-level player. After entering the door of Huarui Laboratory, Arnold couldn't help but whisper with Frank: "It's only been a few days?" Haven't you heard that he is doing this job?"

"Of course not. He was working on the catalyst for coenzyme Q10 a few days ago. Didn't he write this book in the past two months? It sold very well and is a professional bestseller." Franky is indeed paying attention to Yang Rui for a long time. If it weren't for China's developed media and information industry in Europe and the United States, Franky would have investigated Yang Rui long ago.

Arnold was the person in charge of the catalyst contract with Yang Rui two months ago. During his stay in Beijing, he was basically negotiating terms with companies in Japan and Norway.

In other words, several multinational companies are dragging this way. They want to see the development of the situation and lower Yang Rui's quotation.

After all, no matter how high the profit of drugs is, it is not justified that they will give Yang Rui 5% of their dry shares in vain, and it is a dividend for global sales. Although Coenzyme Q10 is far from a blockbuster-grade drug, even quasi-blockbusters are included, it is a medium-sized variety with annual sales of over 100 million yuan in a single company. Besides, what if it becomes a blockbuster?

You can't give Yang Rui $50 million every year. This kind of agreement will hurt if the British think about it.

Now, with the sales volume of Coenzyme Q10, the revenue dividend is quite high.

Drugs are products with extremely high profits. The only high-priced raw material used by semi-synthetic Coenzyme Q10 is refined solanol. In the case of stable market, Jielikan usually gets more than 30% of the profit, and a 2% revenue dividend is equivalent to 0.6% of the dividend. Based on the current annual sales of Coenzyme Q10, it is equivalent to a stable income of US$600,000 per year, which is also a lot and there is room for growth.

This is also an excellent condition for biologists to get. Even if a well-known American professor signs a contract, he can get 600,000 US dollars in a stable income from drought and flood. Then he is happy to jump.

Unfortunately, Yang Rui was not satisfied.

Arnold and his colleagues from other countries could only use it tacitly.

However, this is just a catalyst formula for Coenzyme Q10. If it were replaced with big things like interferon, each company would definitely not have any tacit understanding and would have been snatched up long ago.

In order to obtain a drug, the price that large pharmaceutical companies are willing to pay is unimaginable to ordinary people. For example, in order to obtain Lipitor, Pfizer eventually acquired its development company warnerlambert for US$82.4 billion. While the latter's shareholders made a fortune, Pfizer also obtained a total sales of US$130 billion from Lipitor, with its peak annual sales of US$13 billion, which is more than the government taxes in many countries.

However, a catalyst that can increase the yield of a drug is not an exclusive drug after all.

Arnold also put down the catalyst for the time being, looked through Yang Rui's experimental records, and asked: "What kind of cooperation do you want?"

"This is our first time developing a drug, so any cooperation is needed." Yang Rui shrugged and said, "It's mainly about information. If you want it, I can pay a consultation fee."

“Consultation fee? How much?”

“$10,000, reimbursement of air tickets and hotels.”

Arnold laughed in silence: "Ten thousand dollars is not enough to hire an investigator."

"I know." Yang Rui smiled.

Arnold's face changed: "Do you want Jelikon to do it in vain?"

"You don't have any bad things to send two people to participate and keep abreast of our progress at any time, right?"

"That's impossible." Arnold smiled. He wanted to say that it was almost the same for you to give the formula of Coenzyme Q10 catalyst to Jielikan, but it was not suitable for this time to mention it, so Arnold endured it.

Yang Rui shrugged and said, "Then don't cooperate. I'll ask you to be observers. If you want to say it, just say it. If you don't want to say it, it's your advantage, right?"

"Don't sign a contract?" Arnold's heart moved. It was indeed not harmful to understand the situation unilaterally.

Yang Rui shook his head: "At least sign a confidentiality contract."

"What else should I observe after signing a contract? An observer who cannot report it..."

"Just report the results, and it's all right to save the process." If the deferrosterone, which has just reached the synthesis stage, is not leaked as long as it is not allowed to be viewed by a specialized pharmacist or not taking photos, it actually won't reveal much.

Arnold was really curious because of Yang Rui's relationship and couldn't help but hesitate.

"It's better, you can be an observer for a day first, and then let's talk about it." Yang Rui then asked the company lawyer waiting in the laboratory to come over and sign the confidentiality agreement for Arnold.

Arnold refused, looked carefully at the agreement and signed the name.

"Old Wei, show it to the British gentlemen." Yang Rui sent the two men a white coat, and led them into the laboratory and introduced the iron-detoxified ferrosterone.

It is impossible for Yang Rui to offer a price to Jielikang normally because he cannot offer a price. The medical industry is an industry with a sound and abnormal industrial chain. Every job has a price, and it is ridiculously expensive.

For example, the most annoying clinical trials, many people think that clinical trials are drug research conducted by pharmaceutical companies in conjunction with hospitals or independent drug research. But in fact, there were clinical trial companies in Europe and the United States a long time ago. They specifically provide clinical trial services to various pharmaceutical companies, with annual sales exceeding 1 billion.

As for professional consulting companies, they are usually fooling people, but the fees are even more expensive, and the price of millions of dollars is just the beginning.

Now, pharmaceutical companies often spend tens of millions or even hundreds of millions of dollars for preclinical research, half of which is spent outside the laboratory, and Yang Rui cannot afford this money.
Chapter completed!